HC ADVISORS, LLC – CRISPR Therapeutics AG Transaction History
HC ADVISORS, LLC portfolio value:
$3.52M
portfolio value
HC ADVISORS, LLC quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +625.83% | 46.51K shares | 3.07M | $65.35 | 53.94K |
| Q2 2022 | share | Increase | +2.12% | 154 shares | -5K | $60.77 | 7.43K |
| Q1 2022 | share | Decrease | -14.27% | -1.21K shares | -186K | $62.77 | 7.27K |
| Q4 2021 | share | Increase | +47.63% | 2.73K shares | -1K | $78.85 | 8.48K |
| Q3 2021 | share | Increase | +0.75% | 43 shares | -280K | $111.93 | 5.75K |
| Q2 2021 | share | Increase | +23.26% | 1.07K shares | 360K | $161.89 | 5.70K |
| Q1 2021 | share | Increase | +9.77% | 412 shares | -82K | $121.85 | 4.63K |
| Q4 2020 | share | Increase | +10.13% | 388 shares | 326K | $153.11 | 4.21K |
| Q3 2020 | share | Increase | +4.73% | 173 shares | 51K | $83.64 | 3.83K |
| Q2 2020 | share | Increase | 0.00% | 3.65K shares | 269K | $73.49 | 3.65K |